share_log

Scotiabank Initiates Coverage On NewAmsterdam Pharma With Sector Outperform Rating, Announces Price Target of $35

Moomoo 24/7 ·  Mar 13 17:22

Scotiabank analyst George Farmer initiates coverage on NewAmsterdam Pharma (NASDAQ:NAMS) with a Sector Outperform rating and announces Price Target of $35.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment